
Publikationen von Monika Schreckenbach
Alle Typen
Zeitschriftenartikel (7)
1.
Zeitschriftenartikel
51, S. 20 - 32 (2021)
MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans. EUROPEAN NEUROPSYCHOPHARMACOLOGY 2.
Zeitschriftenartikel
15, 100401 (2021)
Analysis of the cerebellar molecular stress response led to first evidence of a role for FKBP51 in brain FKBP52 expression in mice and humans. NEUROBIOLOGY OF STRESS 3.
Zeitschriftenartikel
20 (5), S. 564 - 581 (2019)
The Dissociative Subtype of PTSD Interview (DSP-I): Development and Psychometric Properties. JOURNAL OF TRAUMA & DISSOCIATION 4.
Zeitschriftenartikel
100, S. 254 - 263 (2019)
PTSD psychotherapy improves blood pressure but leaves HPA axis feedback sensitivity stable and unaffected: First evidence from a pre-post treatment study. PSYCHONEUROENDOCRINOLOGY 5.
Zeitschriftenartikel
15, 40 (2017)
Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC MEDICINE 6.
Zeitschriftenartikel
7, 44277 (2017)
New insights into the intracellular distribution pattern of cationic amphiphilic drugs. SCIENTIFIC REPORTS 7.
Zeitschriftenartikel
55, S. 102 - 115 (2015)
Identification and characterization of HPA-axis reactivity endophenotypes in a cohort of female PTSD patients. PSYCHONEUROENDOCRINOLOGY